Wednesday, November 10, 2021 9:09:07 AM
Looking like a runner today.!$$$
Recent RNXT News
- RenovoRx to Present at the Alliance Global Partners Virtual Annual Healthcare Company Showcase on May 20th • GlobeNewswire Inc. • 05/19/2026 12:30:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/15/2026 09:25:44 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:19:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:17:07 PM
- RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter • GlobeNewswire Inc. • 05/14/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 08:00:40 PM
- RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET • GlobeNewswire Inc. • 04/29/2026 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/28/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/27/2026 09:20:10 PM
- RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/16/2026 09:10:26 PM
- Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:02 AM
- RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 • GlobeNewswire Inc. • 04/01/2026 06:20:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/31/2026 08:19:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:38:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:03 PM
- RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 11:00:10 AM
- RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:57 AM
